Drug recall · June 14, 2023
Travoprost Ophthalmic Solution recall
Why: Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorporated, Camarillo, CA 93012, a) NDC 51407-731-25 (2.5 mL bottle), b) NDC 51407-731-05 (5 mL bottle).
- Lots / codes
Lot #s: a) GS049666, GS049807, Exp: 03/31/2024; b) GS049667, GS051447, Exp: 09/30/2024.
- Quantity
- 1,920 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Nationwide in the USA
- Initiated
- May 25, 2023 · Voluntary: Firm initiated
- Classified
- June 6, 2023
- Reported
- June 14, 2023
- Ended
- August 8, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Travoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.